647 related articles for article (PubMed ID: 12405864)
1. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.
De Paepe P; Belpaire FM; Buylaert WA
Clin Pharmacokinet; 2002; 41(14):1135-51. PubMed ID: 12405864
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock.
Varghese JM; Roberts JA; Lipman J
Crit Care Clin; 2011 Jan; 27(1):19-34. PubMed ID: 21144984
[TBL] [Abstract][Full Text] [Related]
3. Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients.
Blanchet B; Jullien V; Vinsonneau C; Tod M
Clin Pharmacokinet; 2008; 47(10):635-54. PubMed ID: 18783295
[TBL] [Abstract][Full Text] [Related]
4. Plasma pharmacokinetics of antimicrobial agents in critically ill patients.
Pea F
Curr Clin Pharmacol; 2013 Feb; 8(1):5-12. PubMed ID: 22946868
[TBL] [Abstract][Full Text] [Related]
5. The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?
Blot S; Lipman J; Roberts DM; Roberts JA
Diagn Microbiol Infect Dis; 2014 May; 79(1):77-84. PubMed ID: 24602849
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetic and pharmacodynamic aspects in antibiotic treatment].
Bellmann R
Med Klin Intensivmed Notfmed; 2014 Apr; 109(3):162-6. PubMed ID: 24643839
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
Roberts JA; Lipman J
Clin Pharmacokinet; 2006; 45(8):755-73. PubMed ID: 16884316
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics in patients with burns.
Jaehde U; Sörgel F
Clin Pharmacokinet; 1995 Jul; 29(1):15-28. PubMed ID: 7586895
[TBL] [Abstract][Full Text] [Related]
9. [Adequate anti-infective treatment : Importance of individual dosing and application].
Brinkmann A; Röhr AC; Köberer A; Fuchs T; Krüger WA; König C; Richter D; Weigand MA; Frey OR
Anaesthesist; 2018 Jun; 67(6):461-476. PubMed ID: 29766208
[TBL] [Abstract][Full Text] [Related]
10. Physiological changes in the critically ill patient with sepsis.
Hosein S; Udy AA; Lipman J
Curr Pharm Biotechnol; 2011 Dec; 12(12):1991-5. PubMed ID: 21554219
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics and Monte Carlo dosing simulations of meropenem during the early phase of severe sepsis and septic shock in critically ill patients in intensive care units.
Jaruratanasirikul S; Thengyai S; Wongpoowarak W; Wattanavijitkul T; Tangkitwanitjaroen K; Sukarnjanaset W; Jullangkoon M; Samaeng M
Antimicrob Agents Chemother; 2015; 59(6):2995-3001. PubMed ID: 25753628
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of drugs used in critically ill adults.
Power BM; Forbes AM; van Heerden PV; Ilett KF
Clin Pharmacokinet; 1998 Jan; 34(1):25-56. PubMed ID: 9474472
[TBL] [Abstract][Full Text] [Related]
13. A Phase II study of polyclonal anti-TNF-α (AZD9773) in Japanese patients with severe sepsis and/or septic shock.
Aikawa N; Takahashi T; Fujimi S; Yokoyama T; Yoshihara K; Ikeda T; Sadamitsu D; Momozawa M; Maruyama T
J Infect Chemother; 2013 Oct; 19(5):931-40. PubMed ID: 23681364
[TBL] [Abstract][Full Text] [Related]
14. Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
Bosilkovska M; Walder B; Besson M; Daali Y; Desmeules J
Drugs; 2012 Aug; 72(12):1645-69. PubMed ID: 22867045
[TBL] [Abstract][Full Text] [Related]
15. Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.
Radke C; Horn D; Lanckohr C; Ellger B; Meyer M; Eissing T; Hempel G
Clin Pharmacokinet; 2017 Jul; 56(7):759-779. PubMed ID: 28039606
[TBL] [Abstract][Full Text] [Related]
16. The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans.
Gwilt PR; Nahhas RR; Tracewell WG
Clin Pharmacokinet; 1991 Jun; 20(6):477-90. PubMed ID: 2044331
[TBL] [Abstract][Full Text] [Related]
17. The clinical pharmacokinetics of levofloxacin.
Fish DN; Chow AT
Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
[TBL] [Abstract][Full Text] [Related]
18. Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.
Chen ML
Clin Pharmacokinet; 2006; 45(10):957-64. PubMed ID: 16984210
[TBL] [Abstract][Full Text] [Related]
19. Sepsis/septic shock: participation of the microcirculation: an abbreviated review.
Hinshaw LB
Crit Care Med; 1996 Jun; 24(6):1072-8. PubMed ID: 8681576
[TBL] [Abstract][Full Text] [Related]
20. Current treatment of sepsis and endotoxaemia.
Periti P
Expert Opin Pharmacother; 2000 Sep; 1(6):1203-17. PubMed ID: 11249488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
